News

Replimune Group's RP1 oncolytic virus therapy faced an FDA rejection, raising concerns about the platform's viability in ...
SHELTON, CT / ACCESS Newswire / July 30, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the ...
In Nigeria, over 20 million Nigerians are living with hepatitis B or C, with 18.2 million infected with hepatitis B and 2.5 ...
The modelling and simulation research team at the NRC's Automotive and Surface Transportation Research Centre is a leader in ...
Untreated hepatitis causes 4,252 Nigerian deaths annually, with over 20 million infected and over N13trn in economic losses, ...
Researchers with Baylor College of Medicine and Texas A&M AgriLife Research collaborated with the U.S. Department of Agriculture Agricultural Research Service, SCINet project and Ag100Pest Initiative ...